journal article·2025-04-01

Effervescent Microneedles for the Codelivery of Chitosan Nanoparticles and Indocyanine Green To Enhance the Treatment of Diet-Induced Obesity in Mice

Maoqi Luo, Yunxiao Zhang, Siwuxie He, Yuyue Guo, Xi Cao, Tao Gong, Zhirong Zhang, Li Deng, Yao Fu

ACS Nano· Volume 19· Issue 12
Publisher page

Abstract

Obesity is a major global health challenge, significantly elevating the risk of cardiovascular disease and type II diabetes. In this study, we identified that self-assembled stearic-acid-modified chitosan oligosaccharide (COA) nanoparticles can efficiently degrade lipid droplets in adipocytes via autolysosomal pathways. By integrating COA nanoparticles with photothermal therapy (PTT), we developed a combination therapy delivered through an effervescent microneedle (MN) patch for treating diet-induced obesity in mice. The effervescent MN patch demonstrated superior skin penetration due to the efficient separation of the needle tips from the backing layer. Over a four-week treatment period, the COA nanoparticle and indocyanine green coloaded MN patches dramatically reduced body weight and white adipose tissue in obese mice without affecting their food intake. Histological analysis further revealed a reduced lipid droplet size and increased expression of UCP-1 within adipose tissues in vivo. Additionally, the combination therapy improved glucose metabolism and insulin sensitivity in obese mice. These findings suggest that COA nanoparticles delivered via an MN patch, when combined with localized PTT, effectively combat obesity and its associated metabolic complications in an obese mouse model. This approach presents a promising alternative to oral and injectable weight loss medications, offering improved efficacy with fewer side effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antioxidant Activity and Oxidative Stress · Advancements in Transdermal Drug Delivery · Biochemical Analysis and Sensing Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Drug Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy

Sichuan University

School of Pharmacy

The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, and the Grade 3 Pharmaceutical Chemistry Laboratory of State Administrate of Traditional Chinese Medicine

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Higher Education Discipline Innovation Project · MOE Key Laboratory of Drug Targeting and Drug Delivery System

References (44)

Show source-provided references
1. Federation, W. O. World Obesity Atlas 2024. https://data.worldobesity.org/publications/?cat=22.2024.02.20.
2. 10.1016/S0140-6736(22)02403-510.1016/S0140-6736(22)02403-5 ↗
3. 10.1016/j.cpcardiol.2017.04.00410.1016/j.cpcardiol.2017.04.004 ↗
4. 10.1038/s41569-020-00465-510.1038/s41569-020-00465-5 ↗
5. 10.1016/j.numecd.2024.05.00110.1016/j.numecd.2024.05.001 ↗
6. 10.1021/acsnano.7b0434810.1021/acsnano.7b04348 ↗
7. 10.1021/acsptsci.1c0016710.1021/acsptsci.1c00167 ↗
8. 10.1152/physrev.00028.202010.1152/physrev.00028.2020 ↗
9. 10.1016/j.ejphar.2024.17686410.1016/j.ejphar.2024.176864 ↗
10. 10.1016/j.bcp.2022.11501210.1016/j.bcp.2022.115012 ↗
11. 10.1016/j.dsx.2024.10307510.1016/j.dsx.2024.103075 ↗
12. 10.1016/j.eclinm.2023.10188210.1016/j.eclinm.2023.101882 ↗
13. 10.1016/S2213-8587(24)00182-710.1016/S2213-8587(24)00182-7 ↗
14. 10.1080/17512433.2023.227919210.1080/17512433.2023.2279192 ↗
15. 10.7759/cureus.6628010.7759/cureus.66280 ↗
16. 10.1038/s41580-018-0085-z10.1038/s41580-018-0085-z ↗
17. 10.1038/s41574-023-00845-010.1038/s41574-023-00845-0 ↗
18. 10.1038/s41565-022-01249-310.1038/s41565-022-01249-3 ↗
19. 10.1016/j.biomaterials.2022.12185010.1016/j.biomaterials.2022.121850 ↗
20. 10.4161/auto.6.4.1161210.4161/auto.6.4.11612 ↗
21. 10.1038/s41422-021-00532-710.1038/s41422-021-00532-7 ↗
22. 10.1080/15548627.2021.196761610.1080/15548627.2021.1967616 ↗
23. 10.1016/j.carbpol.2015.12.01610.1016/j.carbpol.2015.12.016 ↗
24. 10.1021/acsami.4c0966510.1021/acsami.4c09665 ↗
25. 10.1002/adma.20221090310.1002/adma.202210903 ↗
26. 10.1002/smll.20230175110.1002/smll.202301751 ↗
27. 10.1016/j.biomaterials.2024.12268710.1016/j.biomaterials.2024.122687 ↗
28. 10.1016/j.jconrel.2024.06.01310.1016/j.jconrel.2024.06.013 ↗
29. 10.1016/j.eng.2023.05.00910.1016/j.eng.2023.05.009 ↗
30. 10.1016/j.ijpharm.2020.11967310.1016/j.ijpharm.2020.119673 ↗
31. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
32. 10.1021/acsnano.8b0957310.1021/acsnano.8b09573 ↗
33. 10.1016/j.jddst.2022.10398410.1016/j.jddst.2022.103984 ↗
34. 10.1021/acsabm.3c0112810.1021/acsabm.3c01128 ↗
35. 10.1016/j.jmbbm.2021.10438410.1016/j.jmbbm.2021.104384 ↗
36. 10.1080/10255842.2011.59648110.1080/10255842.2011.596481 ↗
37. 10.1016/j.jcis.2022.03.04610.1016/j.jcis.2022.03.046 ↗
38. 10.1126/sciadv.aaw814510.1126/sciadv.aaw8145 ↗
39. 10.1038/nmat244210.1038/nmat2442 ↗
40. 10.1016/j.actbio.2024.04.02910.1016/j.actbio.2024.04.029 ↗
41. 10.3390/cells808079510.3390/cells8080795 ↗
42. 10.1021/nn800511k10.1021/nn800511k ↗
43. 10.1002/smll.20230736610.1002/smll.202307366 ↗
44. 10.1016/j.carbpol.2020.11641310.1016/j.carbpol.2020.116413 ↗